OMERACT-OARSI ‘strict responders’ analysis from results of a randomized, double-blind, placebo-controlled phase 1 study of a novel, intra-articular, injectable, Wnt inhibitor (SM04690) in the treatment of osteoarthritis of the knee

Saved in:
Bibliographic Details
Published inOsteoarthritis and cartilage Vol. 24; p. S187
Main Authors Yazici, Y, Tambiah, J, Swearingen, C.J, DiFrancesco, A, Strand, V
Format Journal Article
LanguageEnglish
Published Elsevier Ltd 01.04.2016
Subjects
Rheumatology
Online AccessGet full text

Cover

More Information
ISSN:1063-4584
1522-9653
DOI:10.1016/j.joca.2016.01.367